Piper Jaffray and William Blair will be the joint bookrunning managers
By Devika Patel
Knoxville, Tenn., Feb. 12 - Eagle Pharmaceuticals, Inc. said it priced its $50.25 million initial public offering of stock with a $7.54 million greenshoe. The deal was announced Dec. 20.
The company will sell 3.35 million common shares at $15.00 apiece.
Piper Jaffray & Co. and William Blair & Co., LLC are the joint bookrunners
Settlement is expected Feb. 18.
Proceeds will be used for research and development, sales and marketing, working capital and general corporate purposes.
The specialty pharmaceutical company is based in Woodcliff Lake, N.J. It expects to list its common stock on an exchange under the symbol "EGRX."
| Issuer: | Eagle Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $50.25 million
|
| Greenshoe: | $7,537,500
|
| Shares: | 3.35 million
|
| Price: | $15.00
|
| Warrants: | No
|
| Bookrunners: | Piper Jaffray & Co. and William Blair & Co., LLC
|
| Co-manager: | Cantor Fitzgerald & Co.
|
| Announcement date: | Dec. 20
|
| Pricing date: | Feb. 12
|
| Settlement date: | Feb. 18
|
| Stock exchange: | Nasdaq: EGRX
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
